# Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

> **NCT02127073** · PHASE2 · TERMINATED · sponsor: **Montefiore Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Breast Cancer
- Ductal Carcinoma in Situ

## Interventions

- **DRUG:** Intranasal Oxytocin

## Key facts

- **NCT ID:** NCT02127073
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01-30
- **Primary completion:** 2017-01-18
- **Final completion:** 2017-09-18
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Could not identify collaborator and secure additional funding after transferring the record to Montefiore Medical Center
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02127073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02127073, "Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02127073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
